NDC 0310-6627

SymlinPen

Pramlintide Acetate

SymlinPen is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Pramlintide Acetate.

Product ID0310-6627_15ee192e-97e1-4867-9b0d-b093b841e939
NDC0310-6627
Product TypeHuman Prescription Drug
Proprietary NameSymlinPen
Generic NamePramlintide Acetate
Dosage FormInjection
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2015-01-08
Marketing CategoryNDA / NDA
Application NumberNDA021332
Labeler NameAstraZeneca Pharmaceuticals LP
Substance NamePRAMLINTIDE ACETATE
Active Ingredient Strength1000 ug/mL
Pharm ClassesAmylin Agonists [MoA],Amylin Analog [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0310-6627-02

2 CARTRIDGE in 1 CARTON (0310-6627-02) > 2.7 mL in 1 CARTRIDGE
Marketing Start Date2015-01-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0310-6627-02 [00310662702]

SymlinPen INJECTION
Marketing CategoryNDA
Application NumberNDA021332
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2015-01-08

Drug Details

Active Ingredients

IngredientStrength
PRAMLINTIDE ACETATE1000 ug/mL

OpenFDA Data

SPL SET ID:4aea30ff-eb0d-45c1-b114-3127966328ff
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 861043
  • 861042
  • 861045
  • 861044
  • Pharmacological Class

    • Amylin Agonists [MoA]
    • Amylin Analog [EPC]

    NDC Crossover Matching brand name "SymlinPen" or generic name "Pramlintide Acetate"

    NDCBrand NameGeneric Name
    0310-6615SymlinPenpramlintide acetate
    0310-6627SymlinPenpramlintide acetate

    Trademark Results [SymlinPen]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    SYMLINPEN
    SYMLINPEN
    78301872 3419705 Live/Registered
    AMYLIN PHARMACEUTICALS, LLC
    2003-09-17

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.